Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Respiratory Institute Wiesbaden, known in German as Atemwegsinstitut Wiesbaden, is a specialized clinical research organization and study center based in Wiesbaden, Germany. The institute focuses exclusively on the investigation of respiratory diseases, including asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis. It conducts Phase II, III, and IV clinical trials, providing high-quality data for pharmaceutical and biotechnology clients worldwide. Led by Dr. Kai-Michael Beeh, the center is renowned for its expertise in respiratory physiology and advanced diagnostic techniques. The institute plays a significant role in the clinical validation of novel inhaled medications and therapeutic strategies through its comprehensive study management services.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Respiratory Institute Wiesbaden.